Inventor · Pomezia, IT

Elisabetta Bianchi

30Patents
4h-index
93Co-inventors
66Inventor score

Filing activity: Nov 8, 1990 → Sep 27, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US7928058B2 Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition Human Necessities 23 Active
US8969294B2 Glucagon/GLP-1 receptor co-agonists Human Necessities 15 Active
US5196512A Synthetic peptides useful as universal carriers for the preparation of immunogenic conjugates and their use in the development of synthetic vaccines Emerging Cross-Sectional Technologies 6 Expired
US11530244B2 Cyclic polypeptides for PCSK9 inhibition Human Necessities 4 Active
US6197536A Methodology to produce, and purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease Chemistry; Metallurgy 2 Expired
US8629101B2 Cholesterol derivatives of inhibitors of viral fusion Emerging Cross-Sectional Technologies 2 Active
US7811577B2 Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity Physics 2 Active
US9593155B2 Oxyntomodulin analogs Human Necessities 1 Active
US8268779B2 Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition Human Necessities 1 Active
US11427616B2 PCSK9 antagonist compounds Human Necessities 1 Active
US7744887B2 Human antibodies interacting with HIV gp41 Physics 1 Expired
US10961295B2 Modified lipidated Relaxin B chain peptides and their therapeutic use Human Necessities 1 Active
US10988524B2 Modified relaxin B chain peptides and their therapeutic use Human Necessities 1 Active
US10988523B2 Modified lipidated Relaxin B chain peptides and their therapeutic use Human Necessities 1 Active
US6995177B1 HCV NS3 protease inhibitors Chemistry; Metallurgy 1 Expired
US11306125B2 PCSK9 antagonists bicyclo-compounds Human Necessities 0 Active
US11505575B2 Cyclic polypeptides for PCSK9 inhibition Human Necessities 0 Active
US11932705B2 Cyclic polypeptides for PCSK9 inhibition Human Necessities 0 Active
US11492385B2 Long-acting co-agonists of the glucagon and GLP-1 receptors Human Necessities 0 Active
US10493125B2 Co-agonists of the glucagon and GLP-1 receptors Human Necessities 0 Active
US11773150B2 Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors Chemistry; Metallurgy 0 Active
US12209145B2 PCSK9 antagonist compounds Human Necessities 0 Active
US10800826B2 Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors Chemistry; Metallurgy 0 Active
US10413593B2 Co-agonists of the glucagon and GLP-1 receptors Chemistry; Metallurgy 0 Active
US11725036B2 Modified lipidated relaxin B chain peptides and their therapeutic use Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.